Methadone-Maintained Smokers Switching to E-Cigarettes

Summary

Methadone-Maintained Smokers Switching to E-Cigarettes is a clinical trial^[1].

Key Facts

• Methadone-Maintained Smokers Switching to E-Cigarettes is in the country of United States^[2].
• Methadone-Maintained Smokers Switching to E-Cigarettes's instance of is recorded as clinical trial^[3].
• Methadone-Maintained Smokers Switching to E-Cigarettes's start time is recorded as +2022-03-31T00:00:00Z^[4].
• Methadone-Maintained Smokers Switching to E-Cigarettes's end time is recorded as +2024-06-30T00:00:00Z^[5].
• Methadone-Maintained Smokers Switching to E-Cigarettes's main subject is recorded as tobacco use disorder^[6].
• Methadone-Maintained Smokers Switching to E-Cigarettes's number of participants is recorded as {'unit': '1', 'amount': '+240'}^[7].
• Methadone-Maintained Smokers Switching to E-Cigarettes's title is recorded as Methadone-Maintained Smokers Switching to E-Cigarettes^[8].
• Methadone-Maintained Smokers Switching to E-Cigarettes's short name is recorded as SHINE^[9].
• Methadone-Maintained Smokers Switching to E-Cigarettes's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+21'}^[10].
• Methadone-Maintained Smokers Switching to E-Cigarettes's ClinicalTrials.gov ID is recorded as NCT05206435^[11].
• Methadone-Maintained Smokers Switching to E-Cigarettes's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[12].
• Methadone-Maintained Smokers Switching to E-Cigarettes's research intervention is recorded as Ganglionic Stimulants^[13].
• Methadone-Maintained Smokers Switching to E-Cigarettes's research intervention is recorded as peripheral nervous system agent^[14].
• Methadone-Maintained Smokers Switching to E-Cigarettes's research intervention is recorded as nicotinic agonist^[15].
• Methadone-Maintained Smokers Switching to E-Cigarettes's research intervention is recorded as cholinergic agonist^[16].
• Methadone-Maintained Smokers Switching to E-Cigarettes's research intervention is recorded as cholinergic agent^[17].
• Methadone-Maintained Smokers Switching to E-Cigarettes's research intervention is recorded as neurotransmitter agent^[18].
• Methadone-Maintained Smokers Switching to E-Cigarettes's research intervention is recorded as mechanism of action^[19].
• Methadone-Maintained Smokers Switching to E-Cigarettes's clinical trial phase is recorded as phase IV clinical trial^[20].
• Methadone-Maintained Smokers Switching to E-Cigarettes's research site is recorded as Butler Hospital^[21].
• Methadone-Maintained Smokers Switching to E-Cigarettes's research subject recruitment status is recorded as recruiting^[22].
• Methadone-Maintained Smokers Switching to E-Cigarettes's study type is recorded as interventional study^[23].